Racewicz AJ, Schofield PJ, Cahall DL, Cline GA, Burgio DE: Monthly dosing with risedronate 50 mg on three consecutive days a month compared with daily dosing with risedronate 5 mg: a 6-month pilot study. Curr Med Res Opin; 2007 Dec;23(12):3079-89

 Ste-Marie LG, Brown JP, Beary JF, Matzkin E, Darbie LM, Burgio DE, Racewicz AJ: Comparison of the effects of once-monthly versus once-daily risedronate i n postmenopausal osteoporosis: a phase II, 6-month, multicenter, randomized, double-blind, active-controlled, dose-ranging study. Clin Ther; 2009 Feb;31(2):272-85

 Delmas PD, McClung MR, Zanchetta JR, Racewicz A, Roux C, Benhamou CL, Man Z, Eusebio RA, Beary JF, Burgio DE, Matzkin E, Boonen S: Efficacy and safety of risedronate 150 mg once a month in the treatment of postmenopausal osteoporosis. Bone; 2008 Jan;42(1):36-42